Latest News

MilDef Group AB (publ) ( STO:MILDEF ) defied analyst predictions to release its second-quarter results, which were...

As the Asian markets navigate a landscape marked by fluctuating technology valuations and geopolitical tensions, small-cap stocks have shown resilience, with indices like the S&P MidCap 400 and Russell 2000 demonstrating notable gains year-to-date. In this environment, identifying promising small-cap companies often involves looking for those that are innovating within their sectors and adapting to current economic conditions; Xizi Clean Energy Equipment Manufacturing stands out as one such...

As Asian markets navigate a period of volatility, driven by geopolitical tensions and fluctuations in technology stocks, investors are increasingly looking towards stable income sources such as dividend stocks. In this environment, identifying companies with strong fundamentals and consistent dividend payouts can be an effective strategy for those seeking reliable returns amidst broader market uncertainties.

Readers hoping to buy Naturhouse Health, S.A. ( BME:NTH ) for its dividend will need to make their move shortly, as the...

Artificial intelligence hardware is attracting huge attention after Taiwan Semiconductor Manufacturing Company, or TSMC, committed an extra US$100b to accelerate its Arizona expansion and leaned into advanced 2 nanometer chips as a key future revenue driver. That kind of spending, paired with a US$60b to US$64b capital expenditure outlook and higher U.S. build costs, can ripple across large, well rated chip designers and manufacturers worldwide. This article breaks down how that news ties...

Praxis Precision Medicines (PRAX) drew fresh investor attention after announcing a research collaboration and license agreement with Remagine Labs to develop a multi day iontophoretic transdermal patch for ulixacaltamide in essential tremor. See our latest analysis for Praxis Precision Medicines. The latest collaboration news arrives after a period of mixed momentum for Praxis Precision Medicines, with the share price up 11.37% over 30 days but down 8.22% over 90 days, while the 1 year total...

The Federal Reserve under Kevin Warsh is signaling that inflation control comes first, with markets bracing for possible rate hikes by late 2026 and even sooner. For large US banks and insurance companies, higher rates, rising Treasury yields and pricier borrowing can reshape profitability, risk and investor sentiment. At the same time, data dependency and a lack of clear Fed guidance are keeping volatility elevated. This article examines three financially healthy US financial stocks that...

With inflation expectations easing in key markets, interest rate paths still uncertain and growth signals mixed across regions, investors are looking for companies that can grow earnings without stretching their balance sheets. That is exactly what the Healthy high growth potential screener focuses on by highlighting stocks where analysts expect strong earnings growth over the next 3 years and where the financial position is considered acceptable. In this article, you will see 3 of the...

In recent weeks, TotalEnergies reported second-quarter 2026 production guidance of nearly 2.4 Mboe/d, highlighted reduced Middle East disruptions, advanced offshore Liberia exploration work, and confirmed the first LNG cargo shipment from the ECA LNG terminal in Mexico to Asia. Together, these developments underline how new LNG offtake volumes into Asian markets and improving Middle East production reliability could influence future cash flow resilience across the portfolio. Next, we will...

Stock markets sit near record highs, fueled by enthusiasm around AI, a busy IPO calendar, and heavy share buybacks, but valuations such as the S&P 500 Shiller P/E Ratio also point to rising correction risk. For investors, that mix of excitement and concern makes quality especially important. This article looks at 3 large cap stocks from a quality screener that appear closely tied to these market themes. Each stock has been chosen for its financial strength and potential sensitivity to AI...

Genesis Energy (GEL) announced a higher quarterly cash distribution for common and preferred unitholders, with the new payouts scheduled for mid August 2026. This move has sharpened investor focus on the stock. See our latest analysis for Genesis Energy. Against this higher distribution backdrop, Genesis Energy’s short term share price performance has been mixed, with the stock down 1.94% over the last day and 12.18% over 90 days. Its 3 year total shareholder return of 75.86% and 5 year total...

Amazon agreement puts Electrovaya in focus Electrovaya (TSX:ELVA) is back on investors’ radar after announcing a commercial agreement and warrant transaction with Amazon related to its Infinity Battery Technology and its potential use in material handling, robotics, and energy storage. See our latest analysis for Electrovaya. Recent trading shows mixed momentum for Electrovaya, with the share price down 8.28% over the past 30 days but up 20.93% year to date, while the 1 year total shareholder...

Northern Trust’s new Invesco mandate and why it matters for shareholders Northern Trust (NTRS) is back in focus after Invesco appointed the company to provide administration, custody and depositary services for a new Irish mutual fund range using swap based index replication. This mandate extends Northern Trust’s existing work across Invesco’s synthetic ETF and digital asset platforms, giving shareholders another data point on how the firm is positioning its asset servicing franchise around...

Beijer Alma AB (publ) has reported its Q2 2026 results, with sales rising to SEK 2,131 million and net income reaching SEK 216 million, alongside higher basic earnings per share from continuing operations compared with the same quarter last year. Across the first half of 2026, the company’s combination of modestly higher sales and much stronger profitability points to more efficient operations and improved earnings quality. We’ll now examine how this sharp jump in quarterly net income and...

With inflation pressures easing in many regions but energy and geopolitics keeping markets on edge, investors are looking for companies that pair solid financial footing with room for earnings growth. That is exactly what the Healthy high growth potential screener aims to highlight by focusing on stocks that analysts expect to grow earnings strongly over the next 3 years while staying in acceptable financial shape. In this article, you will see 3 stocks from this screener that capture that...

Old Second Bancorp (OSBC) recently disclosed that board member John Williams, Jr. resigned in line with its age based Director Resignation Policy. This is a routine governance event that still invites a closer look at the stock’s setup. See our latest analysis for Old Second Bancorp. Old Second Bancorp’s share price has had a firm run, with a 7-day share price return of 3.28%, a 30-day share price return of 7.99%, and a year to date share price return of 21.36%. Total shareholder return over...

In recent days, analysts cut their earnings estimates for Pilgrim's Pride for both the current quarter and fiscal year, citing expectations for a sharp year-over-year profit decline. This reassessment of the profit outlook has sharpened attention on whether current earnings pressures align with views that the company’s shares still trade below intrinsic value estimates. Now we’ll explore how these earnings downgrades and the softer profit outlook might reshape Pilgrim’s Pride’s existing...

AerCap Holdings (NYSE:AER) recently agreed to lease three Boeing 777-300ERSF converted freighters to China Southern Air Logistics, with deliveries scheduled from late 2027 through mid 2028. This agreement reinforces its role in the air cargo leasing segment. See our latest analysis for AerCap Holdings. At a share price of $146.97, AerCap Holdings has moved slightly lower over the past week but is modestly higher over the past month. A 1 year total shareholder return of about 32% and a 5 year...

In July 2026, Orion Oyj raised its full-year 2026 guidance, tightening net sales to €2,000 million–€2,100 million and operating profit to €650 million–€750 million, alongside reporting strong second-quarter and first-half results with higher sales, net income and earnings per share than a year earlier. The company linked its improved outlook to robust collaboration income and commercial performance, while emphasizing that partnership-related payments remain difficult to forecast due to their...

Recent concerns about softer subscriber growth, declining operating margins, and expectations for a lower free cash flow margin have pushed New York Times (NYT) into sharper focus for investors reassessing risk and earnings durability. See our latest analysis for New York Times. At a share price of US$75.93, New York Times has seen short term share price momentum soften, with the stock down over the last 90 days but supported by an 8.75% year to date share price return and a 44.14% 1 year...

Why a2 Milk’s upgraded guidance matters for investors a2 Milk (NZSE:ATM) has drawn fresh attention after revising its fiscal 2026 outlook, telling investors to expect revenue of about $1.97b, more than 12% above fiscal 2025, and net profit after tax slightly higher than last year. This shift from earlier guidance for similar or lower profit makes the update a useful moment to reassess how a2 Milk’s growth profile, margins and regional mix line up with the current share price and recent share...

Sterling Infrastructure, Inc. recently amended and restated its credit agreement, extending the maturity of its expanded US$1.50 billion revolving credit facility to July 2031, increasing incremental capacity, lowering interest costs, and easing certain covenants, while also announcing that long-time General Counsel Mark D. Wolf plans to retire later this year and will assist with the transition. This larger, longer-dated, and more flexible credit facility gives Sterling Infrastructure...

Nektar Therapeutics has produced very strong share price gains over the last three years, yet on Simply Wall St’s broader checks it screens as expensive rather than a clear bargain. This puts the recent rally under scrutiny for valuation focused investors. The stock has returned roughly 7x over three years, which makes it important to question how much future potential is already reflected in the current share price. Expectations around Nektar Therapeutics' ability to translate its pipeline...

Hillgrove Resources has approved the development of the Emily Star deposit as a third underground mining front at its Kanmantoo Copper Mine in South Australia, committing A$20 million to A$22 million and targeting initial stoping in the second half of 2027. This additional mining front is intended to increase operational flexibility and underpin sustained copper production over Kanmantoo’s mine life, potentially reshaping how the company manages throughput, grade profiles, and longer-term...